Proxima Clinical Research, Inc. Appoints David T. Novotny, as Chief Strategy Officer
David T. Novotny was recently named Chief Strategy Officer of Proxima Clinical Research, Inc., a leader in clinical trial and strategic services. Mr. Novotny will be a member of the executive management team and drive the strategy of the organization, particularly in the medical device sector.
Proxima Clinical Research, Inc. Participates in FDA Sponsored Pediatric Medical Device Consortium
The Southwest National Pediatric Device Consortium (SWPDC), anchored by Texas Children’s Hospital and Baylor College of Medicine, recently received a prestigious P50 grant from the U.S. Food & Drug Administration (FDA).
Xconomy: Proxima Aims to Fill CRO Gap for Houston’s Growing Biotech Community
Medical research is big business in Houston, but life science companies sometimes find they’re missing out on the clinical trial services typically provided by contract research organizations (CROs). Proxima Clinical Research wants to fill that gap, and the new company plans a more customer-focused approach to do it.